HB Wealth Management LLC grew its stake in shares of Exelon Co. (NASDAQ:EXC - Free Report) by 37.8% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 24,322 shares of the company's stock after purchasing an additional 6,672 shares during the quarter. HB Wealth Management LLC's holdings in Exelon were worth $915,000 at the end of the most recent quarter.
A number of other hedge funds also recently added to or reduced their stakes in the business. Foundations Investment Advisors LLC grew its holdings in Exelon by 3.5% during the 3rd quarter. Foundations Investment Advisors LLC now owns 7,533 shares of the company's stock worth $305,000 after acquiring an additional 255 shares in the last quarter. Harbor Capital Advisors Inc. boosted its holdings in shares of Exelon by 1.0% in the 3rd quarter. Harbor Capital Advisors Inc. now owns 28,392 shares of the company's stock valued at $1,151,000 after buying an additional 274 shares in the last quarter. Rosenberg Matthew Hamilton boosted its holdings in shares of Exelon by 12.6% in the 4th quarter. Rosenberg Matthew Hamilton now owns 2,457 shares of the company's stock valued at $92,000 after buying an additional 275 shares in the last quarter. Ballentine Partners LLC boosted its holdings in shares of Exelon by 2.1% in the 3rd quarter. Ballentine Partners LLC now owns 13,922 shares of the company's stock valued at $565,000 after buying an additional 285 shares in the last quarter. Finally, Ledyard National Bank boosted its holdings in shares of Exelon by 5.1% in the 3rd quarter. Ledyard National Bank now owns 6,348 shares of the company's stock valued at $257,000 after buying an additional 308 shares in the last quarter. 80.92% of the stock is owned by hedge funds and other institutional investors.
Exelon Price Performance
Exelon stock traded down $1.22 during trading on Wednesday, reaching $39.22. The company had a trading volume of 7,661,031 shares, compared to its average volume of 5,959,929. The firm's 50-day simple moving average is $38.07 and its 200 day simple moving average is $38.31. Exelon Co. has a 1-year low of $33.35 and a 1-year high of $41.19. The firm has a market capitalization of $39.41 billion, a PE ratio of 16.14, a price-to-earnings-growth ratio of 2.62 and a beta of 0.55. The company has a debt-to-equity ratio of 1.66, a quick ratio of 0.97 and a current ratio of 1.09.
Exelon (NASDAQ:EXC - Get Free Report) last released its quarterly earnings results on Wednesday, October 30th. The company reported $0.71 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.67 by $0.04. Exelon had a net margin of 10.60% and a return on equity of 9.47%. The firm had revenue of $6.15 billion for the quarter, compared to analysts' expectations of $5.85 billion. During the same quarter last year, the company earned $0.67 EPS. The firm's revenue for the quarter was up 2.9% compared to the same quarter last year. As a group, equities research analysts anticipate that Exelon Co. will post 2.46 earnings per share for the current fiscal year.
Exelon Announces Dividend
The firm also recently announced a quarterly dividend, which was paid on Friday, December 13th. Shareholders of record on Monday, November 11th were paid a dividend of $0.38 per share. The ex-dividend date of this dividend was Friday, November 8th. This represents a $1.52 annualized dividend and a yield of 3.88%. Exelon's dividend payout ratio (DPR) is presently 62.55%.
Analyst Upgrades and Downgrades
Several equities analysts recently commented on EXC shares. Morgan Stanley decreased their price objective on shares of Exelon from $46.00 to $44.00 and set an "equal weight" rating for the company in a research report on Friday, November 22nd. Evercore ISI raised shares of Exelon from an "in-line" rating to an "outperform" rating and increased their price objective for the company from $43.00 to $44.00 in a research report on Tuesday. Scotiabank increased their price objective on shares of Exelon from $40.00 to $42.00 and gave the company a "sector perform" rating in a research report on Thursday, December 12th. Finally, Barclays reduced their price target on shares of Exelon from $44.00 to $42.00 and set an "overweight" rating for the company in a research report on Wednesday. Five analysts have rated the stock with a hold rating and four have assigned a buy rating to the company's stock. According to data from MarketBeat, Exelon has an average rating of "Hold" and an average price target of $43.13.
View Our Latest Stock Report on Exelon
Exelon Profile
(
Free Report)
Exelon Corporation, a utility services holding company, engages in the energy distribution and transmission businesses in the United States and Canada. The company is involved in the purchase and regulated retail sale of electricity and natural gas, transmission and distribution of electricity, and distribution of natural gas to retail customers.
Featured Articles
Before you consider Exelon, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exelon wasn't on the list.
While Exelon currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.